Inflammation in human carotid atheroma plaques

Cytokine Growth Factor Rev. 2018 Feb:39:62-70. doi: 10.1016/j.cytogfr.2018.01.006. Epub 2018 Jan 31.

Abstract

Inflammation in carotid atherosclerotic plaque is linked to plaque rupture and cerebrovascular accidents. The balance between pro- and anti-inflammatory mediators governs development of the plaque, and may mediate enhancement of lesion broadening or, on the contrary, delay progression. In addition to macrophages and endothelial cells, smooth muscle cells (SMCs), which are the dominant cell subset in advanced plaques, are crucial players in carotid atherosclerosis development given their ability to differentiate into distinct phenotypes in reponse to specific signals received from the environment of the lesion. Carotid atheroma SMCs actively contribute to the inflammation in the lesion because of their acquired capacity to produce inflammatory mediators. We review the successive stages of carotid atheroma plaque formation via fatty streak early-stage toward more advanced rupture-prone lesions and document involvement of cytokines and chemokines and their cellular sources and targets in plaque progression and rupture.

Keywords: Atherosclerosis; Carotid; Cytokine; Interleukin; Smooth muscle cell; TNF.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Carotid Artery Diseases / pathology*
  • Endothelial Cells / cytology
  • Humans
  • Inflammation / complications*
  • Inflammation Mediators
  • Macrophages / cytology
  • Mice
  • Myocytes, Smooth Muscle / cytology*
  • Plaque, Atherosclerotic / pathology*

Substances

  • Inflammation Mediators